Free Trial

Clever Leaves (CLVR) Competitors

Clever Leaves logo

CLVR vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ACABW, ACABU, BFRIW, and BTMDW

Should you be buying Clever Leaves stock or one of its competitors? The main competitors of Clever Leaves include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Biofrontera (BFRIW), and biote (BTMDW). These companies are all part of the "pharmaceutical products" industry.

Clever Leaves vs.

180 Life Sciences (NASDAQ:ATNFW) and Clever Leaves (NASDAQ:CLVR) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, analyst recommendations, earnings, valuation, profitability, risk, dividends and media sentiment.

6.9% of Clever Leaves shares are owned by institutional investors. 8.2% of Clever Leaves shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Clever Leaves received 13 more outperform votes than 180 Life Sciences when rated by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
Clever LeavesOutperform Votes
13
81.25%
Underperform Votes
3
18.75%

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Clever Leaves N/A N/A N/A

180 Life Sciences has higher earnings, but lower revenue than Clever Leaves.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Clever Leaves$17.42M0.00-$17.90M-$11.31N/A

In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled Clever Leaves'average media sentiment score.

Company Overall Sentiment
180 Life Sciences Neutral
Clever Leaves Neutral

Summary

Clever Leaves beats 180 Life Sciences on 4 of the 4 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLVR vs. The Competition

MetricClever LeavesPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market CapN/A$6.56B$5.23B$8.84B
Dividend YieldN/A8.13%5.54%4.08%
P/E RatioN/A10.4094.1017.64
Price / SalesN/A355.751,238.8890.90
Price / CashN/A53.8241.4336.93
Price / BookN/A10.597.236.54
Net Income-$17.90M$153.02M$119.93M$226.15M

Clever Leaves Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLVR
Clever Leaves
N/AN/AN/AN/A$0.00$17.42M0.00560
ATNFW
180 Life Sciences
N/A$0.01
+9.0%
N/A+7.4%$0.00N/A0.007Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.04
flat
N/A-15.0%$0.00N/A0.002
AIMDW
Ainos
N/A$0.03
flat
N/AN/A$0.00$40,633.000.0040
ALVOW
Alvotech
N/A$3.21
-4.2%
N/AN/A$0.00$391.87M0.004Gap Down
ALVO
Alvotech
2.1297 of 5 stars
$11.93
-4.1%
$18.00
+50.9%
+31.4%$0.00$93.38M-6.721,026
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.08
flat
N/A+71.4%$0.00N/A0.004
ACABU
Atlantic Coastal Acquisition Corp. II
N/A$8.05
-26.8%
N/A-23.6%$0.00N/A0.004Gap Down
BFRIW
Biofrontera
N/A$0.07
+18.2%
N/AN/A$0.00$35.36M0.0070
BTMDW
biote
N/A$0.50
flat
N/A-53.3%$0.00$193.06M0.00N/A

Related Companies and Tools


This page (NASDAQ:CLVR) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners